PMID- 26104826 OWN - NLM STAT- MEDLINE DCOM- 20160329 LR - 20231111 IS - 1872-7123 (Electronic) IS - 0165-1781 (Print) IS - 0165-1781 (Linking) VI - 233 IP - 2 DP - 2015 Aug 30 TI - In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept. PG - 141-7 LID - S0925-4927(15)30008-1 [pii] LID - 10.1016/j.pscychresns.2015.06.001 [doi] AB - We previously reported the rapid and robust clinical effects of ketamine versus saline infusions in a proof-of-concept crossover trial in unmedicated adults with obsessive-compulsive disorder (OCD). This study examined the concurrent neurochemical effects of ketamine versus saline infusions using proton magnetic resonance spectroscopy ((1)H MRS) during the clinical proof-of-concept crossover trial. Levels of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and the excitatory neurochemicals glutamate+glutamine (Glx) were acquired in the medial prefrontal cortex (MPFC), a region implicated in OCD pathology. Seventeen unmedicated OCD adults received two intravenous infusions at least 1 week apart, one of saline and one of ketamine, while lying supine in a 3.0 T GE MR scanner. The order of each infusion pair was randomized. Levels of GABA and Glx were measured in the MPFC before, during, and after each infusion and normalized to water (W). A mixed effects model found that MPFC GABA/W significantly increased over time in the ketamine compared with the saline infusion. In contrast, there were no significant differences in Glx/W between the ketamine and saline infusions. Together with earlier evidence of low cortical GABA in OCD, our findings suggest that models of OCD pathology should consider the role of GABAergic abnormalities in OCD symptomatology. CI - Copyright (c) 2015 Elsevier Ireland Ltd. All rights reserved. FAU - Rodriguez, Carolyn I AU - Rodriguez CI AD - Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA; Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA. Electronic address: cr2163@columbia.edu. FAU - Kegeles, Lawrence S AU - Kegeles LS AD - Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA; Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA; Department of Radiology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA. FAU - Levinson, Amanda AU - Levinson A AD - Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA. FAU - Ogden, R Todd AU - Ogden RT AD - Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA; Department of Biostatistics, Columbia University, Mailman School of Public Health, New York, NY 10032, USA. FAU - Mao, Xiangling AU - Mao X AD - Department of Radiology, Weill Medical College of Cornell University, NY 10021, USA. FAU - Milak, Matthew S AU - Milak MS AD - Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA; Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA. FAU - Vermes, Donna AU - Vermes D AD - Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA; Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA. FAU - Xie, Shan AU - Xie S AD - Analytical Psychopharmacology Laboratory, the Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA. FAU - Hunter, Liane AU - Hunter L AD - Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA. FAU - Flood, Pamela AU - Flood P AD - Department of Anesthesiology, Perioperative and Pain Medicine, Stanford, Palo Alto, CA 94305, USA. FAU - Moore, Holly AU - Moore H AD - Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA; Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA. FAU - Shungu, Dikoma C AU - Shungu DC AD - Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA; Department of Radiology, Weill Medical College of Cornell University, NY 10021, USA. FAU - Simpson, Helen B AU - Simpson HB AD - Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA; Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA. LA - eng GR - K24 MH091555/MH/NIMH NIH HHS/United States GR - K23MH092434/MH/NIMH NIH HHS/United States GR - K24MH09155/MH/NIMH NIH HHS/United States GR - UL1TR000040/TR/NCATS NIH HHS/United States GR - UL1 TR000040/TR/NCATS NIH HHS/United States GR - K23 MH092434/MH/NIMH NIH HHS/United States PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20150606 PL - Ireland TA - Psychiatry Res JT - Psychiatry research JID - 7911385 RN - 0 (Excitatory Amino Acid Antagonists) RN - 0RH81L854J (Glutamine) RN - 3KX376GY7L (Glutamic Acid) RN - 56-12-2 (gamma-Aminobutyric Acid) RN - 690G0D6V8H (Ketamine) SB - IM MH - Adult MH - Cross-Over Studies MH - Excitatory Amino Acid Antagonists/administration & dosage/*pharmacology MH - Female MH - Glutamic Acid/drug effects/*metabolism MH - Glutamine/drug effects/*metabolism MH - Humans MH - Ketamine/administration & dosage/*pharmacology MH - Male MH - Obsessive-Compulsive Disorder/*drug therapy/*metabolism MH - Prefrontal Cortex/drug effects/*metabolism MH - Proton Magnetic Resonance Spectroscopy MH - Treatment Outcome MH - gamma-Aminobutyric Acid/drug effects/*metabolism PMC - PMC4715460 MID - NIHMS705143 OTO - NOTNLM OT - Gamma-aminobutyric acid OT - Glutamate-glutamine OT - Ketamine OT - Magnetic resonance spectroscopy OT - Medial prefrontal cortex OT - Obsessive-compulsive disorder (OCD) EDAT- 2015/06/25 06:00 MHDA- 2016/03/30 06:00 PMCR- 2016/08/30 CRDT- 2015/06/25 06:00 PHST- 2014/11/22 00:00 [received] PHST- 2015/04/18 00:00 [revised] PHST- 2015/06/01 00:00 [accepted] PHST- 2015/06/25 06:00 [entrez] PHST- 2015/06/25 06:00 [pubmed] PHST- 2016/03/30 06:00 [medline] PHST- 2016/08/30 00:00 [pmc-release] AID - S0925-4927(15)30008-1 [pii] AID - 10.1016/j.pscychresns.2015.06.001 [doi] PST - ppublish SO - Psychiatry Res. 2015 Aug 30;233(2):141-7. doi: 10.1016/j.pscychresns.2015.06.001. Epub 2015 Jun 6.